HUDSON; F. MICHAEL

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUDSON; F. MICHAEL.The latest application filed is for "compounds for the treatment of neurodegenerative diseases".

Company Profile

1.11.12

HUDSON; F. MICHAEL - OAKLAND CA
Hudson; F. Michael - Seattle WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For The Treatment Of Neurodegenerative Diseases App 20180002298 - ESPOSITO; LUKE A. ; et al.	2018-01-04
Compounds For The Treatment Of Neurodegenerative Diseases App 20170022174 - ESPOSITO; LUKE A. ; et al.	2017-01-26
Compounds for the treatment of neurodegenerative diseases Grant 9,334,251 - Esposito , et al. May 10, 2	2016-05-10
Compounds for the treatment of Neurodegenerative Diseases App 20150274681 - ESPOSITO; LUKE A. ; et al.	2015-10-01
Compounds for the treatment of neurodegenerative diseases Grant 9,085,549 - Luke , et al. July 21, 2	2015-07-21
Compounds for the treatment of neurodegenerative diseases App 20150011604 - Luke; Esposito A ; et al.	2015-01-08
Compounds, compositions, and methods for the treatment of .beta.-amyloid diseases and synucleinopathies Grant 8,916,598 - Esposito , et al. December 23, 2	2014-12-23
Compounds for the treatment of neurodegenerative diseases Grant 8,865,754 - Esposito , et al. October 21, 2	2014-10-21
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies Grant 8,829,198 - Esposito , et al. September 9, 2	2014-09-09
Compounds For The Treatment Of Neurodegenerative Diseases App 20130338202 - Esposito; Luke A. ; et al.	2013-12-19
Compounds, compositions, and methods for the treatment of .beta.-amyloid diseases and synucleinopathies Grant 8,592,476 - Esposito , et al. November 26, 2	2013-11-26
Compounds for Use in the Detection of Neurodegenerative Diseases App 20120251448 - Hefti; Franz F. ; et al.	2012-10-04
Compounds, Compositions, And Methods For The Treatment Of Beta-amyloid Diseases And Synucleinopathies App 20120252858 - Esposito; Luke A. ; et al.	2012-10-04
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies App 20120035230 - Esposito; Luke A. ; et al.	2012-02-09
Compounds, compositions, and methods for the treatment of synucleinopathies Grant 7,919,530 - Esposito , et al. April 5, 2	2011-04-05
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies App 20100331380 - Esposito; Luke A. ; et al.	2010-12-30
Compounds, Compositions, and Methods for the Treatment of Synucleinopathies App 20100179223 - Esposito; Luke A. ; et al.	2010-07-15
Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies App 20090111863 - Esposito; Luke A. ; et al.	2009-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.